Michael Laposata

8.6k total citations
195 papers, 6.3k citations indexed

About

Michael Laposata is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nutrition and Dietetics. According to data from OpenAlex, Michael Laposata has authored 195 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 46 papers in Pathology and Forensic Medicine and 46 papers in Nutrition and Dietetics. Recurrent topics in Michael Laposata's work include Alcohol Consumption and Health Effects (44 papers), Fatty Acid Research and Health (38 papers) and Clinical Laboratory Practices and Quality Control (30 papers). Michael Laposata is often cited by papers focused on Alcohol Consumption and Health Effects (44 papers), Fatty Acid Research and Health (38 papers) and Clinical Laboratory Practices and Quality Control (30 papers). Michael Laposata collaborates with scholars based in United States, Italy and Hungary. Michael Laposata's co-authors include Elizabeth M. Van Cott, Joanne E. Cluette‐Brown, László Muszbek, Steven D. Freedman, Mario Plebani, Lawrence F. Brass, Robert B. Zurier, Anand S. Dighe, Raneem O. Salem and Catherine Best‐Popescu and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Physical Review Letters.

In The Last Decade

Michael Laposata

192 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Laposata United States 46 1.7k 1.2k 1.1k 914 906 195 6.3k
Jorge Joven Spain 62 3.9k 2.3× 1.1k 1.0× 854 0.8× 571 0.6× 1.9k 2.1× 377 12.2k
Francesco Cipollone Italy 50 1.6k 1.0× 854 0.7× 418 0.4× 634 0.7× 1.5k 1.6× 194 8.1k
Magnus Bäck Sweden 49 2.1k 1.2× 1.3k 1.1× 1.1k 0.9× 1.2k 1.3× 1.6k 1.8× 190 8.5k
Sudhir V. Shah United States 60 3.5k 2.1× 809 0.7× 896 0.8× 1.6k 1.8× 2.3k 2.5× 189 15.5k
Barry I. Freedman United States 65 3.3k 1.9× 1.4k 1.3× 651 0.6× 1.3k 1.4× 1.8k 2.0× 420 16.3k
Ingolf Cascorbi Germany 57 4.1k 2.4× 802 0.7× 398 0.4× 470 0.5× 1.5k 1.6× 234 13.1k
Andrew N. Hoofnagle United States 56 3.4k 2.0× 1.1k 1.0× 1.2k 1.1× 588 0.6× 965 1.1× 266 10.1k
Richard B. Kim Canada 74 3.7k 2.2× 750 0.6× 660 0.6× 550 0.6× 2.0k 2.3× 243 18.5k
Maria F. Lopes‐Virella United States 54 2.1k 1.2× 1.1k 1.0× 695 0.6× 564 0.6× 2.4k 2.6× 225 10.7k
Steven D. Heys United Kingdom 44 1.3k 0.7× 828 0.7× 1.3k 1.2× 804 0.9× 1.2k 1.4× 171 7.4k

Countries citing papers authored by Michael Laposata

Since Specialization
Citations

This map shows the geographic impact of Michael Laposata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Laposata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Laposata more than expected).

Fields of papers citing papers by Michael Laposata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Laposata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Laposata. The network helps show where Michael Laposata may publish in the future.

Co-authorship network of co-authors of Michael Laposata

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Laposata. A scholar is included among the top collaborators of Michael Laposata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Laposata. Michael Laposata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laposata, Michael, et al.. (2024). Impact of diagnostic management team on patient time to diagnosis and percent of accurate and clinically actionable diagnoses. Diagnosis. 11(2). 132–135. 2 indexed citations
2.
Seymour, Robert L., et al.. (2021). Overutilization and underutilization of autoantibody tests in patients with suspected autoimmune disorders. Diagnosis. 8(4). 497–503. 2 indexed citations
3.
Graber, Mark L., Melissa Jones, Kelly T. Gleason, et al.. (2017). The new diagnostic team. Diagnosis. 4(4). 225–238. 67 indexed citations
4.
5.
Laposata, Michael. (2014). Laboratory Medicine: The Diagnosis of Disease in the Clinical Laboratory. 24 indexed citations
6.
Laposata, Michael, et al.. (2011). Increased Elongase 6 and Δ9‐Desaturase Activity are Associated with n‐7 and n‐9 Fatty Acid Changes in Cystic Fibrosis. Lipids. 46(8). 669–677. 20 indexed citations
7.
Mischoulon, David, Catherine Best‐Popescu, Michael Laposata, et al.. (2008). A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. European Neuropsychopharmacology. 18(9). 639–645. 66 indexed citations
8.
Cluette‐Brown, Joanne E., et al.. (2006). Fatty Acid Ethyl Esters in Human Mononuclear Cells: Production by Endogenous Synthesis Greatly Exceeds the Uptake of Preformed Ethyl Esters. Alcoholism Clinical and Experimental Research. 30(3). 560–566. 7 indexed citations
9.
Ollero, Mario, Michael Laposata, Munir M. Zaman, et al.. (2006). Evidence of increased flux to n-6 docosapentaenoic acid in phospholipids of pancreas from cftr−/− knockout mice. Metabolism. 55(9). 1192–1200. 24 indexed citations
10.
Laposata, Michael, et al.. (2005). Children With Signs of Abuse. PubMed. 123(suppl_1). S119–S124. 9 indexed citations
11.
Freedman, Steven D., Paola G. Blanco, Munir M. Zaman, et al.. (2004). Association of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism. New England Journal of Medicine. 350(6). 560–569. 317 indexed citations
12.
Laposata, Michael & Stephen M. Johnson. (2003). Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days: An in vitro study. Clinical Therapeutics. 25(4). 1219–1225. 2 indexed citations
13.
Salem, Raneem O., et al.. (2003). Fatty Acid Ethyl Esters: Ethanol Metabolites That Reflect Ethanol Intake. PubMed. 119(1). 94–99. 45 indexed citations
14.
Fogel, Robert, Cynthia D. Smith, Michael Laposata, et al.. (1999). d -Dimers in the Diagnosis of Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine. 159(5). 1445–1449. 53 indexed citations
15.
Laposata, Michael, et al.. (1998). College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.. PubMed. 122(9). 799–807. 198 indexed citations
16.
Gertler, Jonathan P., Richard P. Cambria, David C. Brewster, et al.. (1996). Coagulation changes during thoracoabdominal aneurysm repair. Journal of Vascular Surgery. 24(6). 936–945. 57 indexed citations
17.
Lewandrowski, Kent, Robert Cheek, David M. Nathan, et al.. (1992). Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing. The American Journal of Medicine. 93(4). 419–426. 42 indexed citations
18.
Pullman‐Mooar, Sally, Michael Laposata, Ralph T. Holman, et al.. (1990). Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma‐linolenic acid. Arthritis & Rheumatism. 33(10). 1526–1533. 55 indexed citations
19.
Baker, Daniel G., Kathrin Krakauer, Guillermo Tate, Michael Laposata, & Robert B. Zurier. (1989). Suppression of human synovial cell proliferation by dihomo‐γ‐linolenic acid. Arthritis & Rheumatism. 32(10). 1273–1281. 49 indexed citations
20.
Tate, Guillermo, Brian F. Mandell, Rashida A. Karmali, et al.. (1988). Suppression of monosodium urate crystal—induced acute inflammation by diets enriched with gamma‐linolenic acid and eicosapentaenoic acid. Arthritis & Rheumatism. 31(12). 1543–1551. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge Joven Breakdown of academic impact, for papers by Francesco Cipollone Breakdown of academic impact, for papers by Magnus Bäck Breakdown of academic impact, for papers by Sudhir V. Shah Breakdown of academic impact, for papers by Barry I. Freedman Breakdown of academic impact, for papers by Ingolf Cascorbi Breakdown of academic impact, for papers by Andrew N. Hoofnagle Breakdown of academic impact, for papers by Richard B. Kim Breakdown of academic impact, for papers by Maria F. Lopes‐Virella Breakdown of academic impact, for papers by Steven D. Heys
Rankless by CCL
2026